The reconstructed skin micronucleus assay (RSMN) in EpiDerm™: Detailed protocol and harmonized scoring atlas

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 720, Issue 1-2, 2011, Pages 42-52

  Dahl, Erica L ^a   Curren, Rodger ^a   Barnett, Brenda C ^b,g   Khambatta, Zubin ^b   Reisinger, Kerstin ^c   Ouedraogo, Gladys ^d   Faquet, Brigitte ^d   Ginestet, Anne Claire ^d   Mun, Greg ^a   Hewitt, Nicola J ^e   Carr, Greg ^b   Pfuhler, Stefan ^c   Aardema, Marilyn J ^f  

^a Institute for in Vitro Sciences   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c HENKEL KGAA   (Germany)

^d L ORÉAL RECHERCHE   (France)

^e SWS ^*  (Germany)

^f Marilyn Aardema Consulting LLC   (United States)

^g PROCTER AND GAMBLE   (United States)

Author keywords

EpiDerm ; Micronucleus; Protocol; Reconstructed skin; Scoring

Indexed keywords

ARTICLE; CELL PROLIFERATION; GENOTOXICITY; LABORATORY TEST; MICRONUCLEUS TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECONSTRUCTED SKIN MICRONUCLEUS ASSAY; SCORING SYSTEM; SKIN; STANDARDIZATION;

GUIDELINES AS TOPIC; HUMANS; MICRONUCLEUS TESTS; MUTAGENS; SKIN; SKIN IRRITANCY TESTS; TISSUE ENGINEERING; VALIDATION STUDIES AS TOPIC;

EID: 79451474927     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.12.001     Document Type: Article

References (14)

1. EU EC-Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Off. J. 2003, L66. 11/03/2003, 26.
2. REACH, http://ec.europa.eu/environment/chemicals/reach/reach_intro.htm.
3. Kirkland D., Aardema M., Müller L., Makoto H. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat. Res. 2006, 608(1):29-42.
4. Kirkland D., Pfuhler S., Tweats D., Aardema M., Corvi R., Darroudi F., Elhajouji A., Glatt H., Hastwell P., Hayashi M., et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat. Res. 2007, 628:31-55.
5. Curren R.D., Mun G.C., Gibson D.P., Aardema M.J. Development of a method for assessing micronucleus induction in a 3D Human skin model (EpiDerm™). Mutat. Res. 2006, 607:192-204.
6. Mun G.C., Aardema M.J., Hu T., Barnett B., Kaluzhny Y., Klausner M., Karetsky V., Dahl E.L., Curren R.D. Further development of the EpiDerm™ 3D reconstructed human skin micronucleus (RSMN) assay. Mutat. Res. 2009, 673:92-99.
7. Hu T., Kaluzhny Y., Mun G.C., Barnett B., Karetsky V., Wilt N., Klausner M., Curren R., Aardema M.J. Intralaboratory and interlaboratory evaluation of the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res. 2009, 673:100-108.
8. Aardema M.J., Barnett B., Khambatta Z., Reisinger K., Ouedraogo-arras G., Faquet B., Ginestet A.-C., Mun G.C., Dahl E.L., Hewitt N.J., Corvi R., Curren R.C. International prevalidation studies of the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility. Mutat. Res. 2010, 701(2):123-131.
9. Pfuhler S., Kirst A., Aardema M.J., Banduhn N., Goebel C., Araki D., Costabel-Farkas M., Dufour E., Fautz R., Harvey J., Hewitt N.J., Hibatallah J., Carmichael P., Macfarlane M., Reisinger K., Rowland J., Schellauf F., Schepky A., Scheel J. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: Genotoxicity. A COLIPA analysis. Mutat. Res. Regul. Toxicol. Pharmacol. 2010, 57(2-3):315-324.
10. Hartung T., Bremer S., Casati S., Coecke S., Corvi R., Fortaner S., Gribaldo L., Halder M., Hoffmann S., Roi A.J., Prieto P., Sabbioni E., Scott L., Worth A., Zuang V. A modular approach to the ECVAM principles on test validity. Altern. Lab. Anim. 2004, 32(5):467-472.
11. OECD, OECD Guideline for the Testing of Chemicals; Draft Proposal for a New Guideline 487: In Vitro Mammalian Cell Micronucleus Test (MNvit). 2009 (accepted 02.11.09). http://www.oecd.org/dataoecd/45/51/43996258.pdf.
12. Nishikawa T., Haresaku M., Adachi K., Masuda M., Hayashi M. Study of a rat skin in vivo micronucleus test: data generated by mitomycin C and methyl methanesulfonate. Mutat. Res. 1999, 444(1):159-166.
13. Fenech M. The in vitro micronucleus technique. Mutat. Res. 2000, 455(1-2):81-95.
14. Fenech M., Chang W.P., Kirsch-Volders M., Holland N., Bonassi S., Zeiger E. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res. 2003, 534:65-75.